Integral Diagnostics Ltd (OTCPK:ITGDF)
$ 2.1 0 (0%) Market Cap: 441.26 Mil Enterprise Value: 635.98 Mil PE Ratio: 0 PB Ratio: 2.25 GF Score: 85/100

Full Year 2024 Integral Diagnostics Ltd Earnings Call Transcript

Aug 27, 2024 / 12:00AM GMT
Release Date Price: $2.1
Operator

Thank you for standing by, and welcome to the Integral Diagnostics IDX FY24 results conference call. (Operator instructions)

I would now like to hand the conference over to Dr. Ian Kadish, CEO. Thank you. Please go ahead.

Ian Kadish
Integral Diagnostics Ltd - Chief Executive Officer, Managing Director, Executive Director

Thank you very much, Jody, and good morning, everybody, who's called in this morning. My name is Ian Kadish. I'm the Managing Director and Chief Executive Officer of Integral Diagnostics. I'm joined here this morning by Craig White. Craig is our Chief Financial Officer. We're privileged to be discussing with you this morning the financial year 2024 results for Integral Diagnostics.

We're proud that we delivered on our values in financial year '24, we delivered excellent patient net promoter scores of plus 84 in Australia and plus 86 in New Zealand. We serve more than a million patients. this year and performed more than 2.5 million exams. We also invested nearly $24 million in CapEx, including investment in new and upgraded

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot